FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary

American Journal of Surgical Pathology

Volumn 35, Issue 4, 2011, Pages 484-494

  Al Agha, Osama M ^a,b   Huwait, Hassan F ^c   Chow, Christine ^a   Yang, Winnie ^b   Senz, Janine ^b   Kalloger, Steve E ^a,b   Huntsman, David G ^a,b   Young, Robert H ^d   Gilks, C Blake ^a,b,c  

^a Genetic Pathology Evaluation Center   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

a inhibin; calretinin; FOXL2; immunohistochemistry; sex cord stromal tumors

Indexed keywords

CALBINDIN; CALRETININ; DNA; FORKHEAD TRANSCRIPTION FACTOR; FOXL2 PROTEIN, HUMAN; INHIBIN; INHIBIN ALPHA SUBUNIT; INHIBIN-ALPHA SUBUNIT; TUMOR MARKER;

ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; POINT MUTATION; PREDICTIVE VALUE; SEX CORD TUMOR; TISSUE MICROARRAY;

CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INHIBINS; OVARIAN NEOPLASMS; POINT MUTATION; PREDICTIVE VALUE OF TESTS; SEX CORD-GONADAL STROMAL TUMORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953168439     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31820a406c     Document Type: Article

References (24)

1. Benayoun BA, Kalfa N, Sultan C, et al. The forkhead factor FOXL2: a novel tumor suppressor? Biochim Biophys Acta. 2010;1:2009.
2. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol. 2001;20:346-352. (Pubitemid 32937449)
3. Cocque J, Pailhoux E, Jaubert F, et al. Evolution and expression of FOXL2. J Med Genet. 2002;39:916-911.
4. Costa MJ, Ames PF, Walls J, et al. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol. 1997;28:1247-1254. (Pubitemid 27492823)
5. Deavers MT, Malpica A, Liu J, et al. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol. 2003;6:584-590. (Pubitemid 36718440)
6. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin. Hum Pathol. 1999;30:856-863. (Pubitemid 29325794)
7. Jamieson S, Butzow R, Anderson N, et al. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Mod Pathol. 2010. (Epub ahead of print)]
8. Kalfa N, Philibert P, Patte C, et al. Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. Fertil Steril. 2007;87:896-901. (Pubitemid 46566352)
9. Kalfa N, Fellous M, Boizet-Bonhoure B, et al. Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol. 2008;4:1810-1813.
10. Kim MS, Hur SY, Yoo NJ, et al. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. J Pathol. 2010;2:47-52.
11. Kommoss F, Oliva E, Bhan AK, et al. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol. 1998;11:656-664. (Pubitemid 28335144)
12. McCluggage WG, Maxwell P. Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology. 2001;38:403-408. (Pubitemid 32863015)
13. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than α-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol. 2002;26:1477-1483. (Pubitemid 35239424)
14. Pannetier M, Fabre S, Batista F, et al. FOXL2 activates P450 aromatase gene transcription: toward a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol. 2006;36:399-413. (Pubitemid 43904936)
15. Rishi M, Howard LH, Bratthauer GL, et al. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumor of the ovary. Am J Surg Pathol. 1997;21:583-589. (Pubitemid 27213074)
16. Schrader KA, Gorbatcheva B, Senz J, et al. The specificity of the FOXL2 (402C→G) somatic mutation: a survey of solid tumors|. PLoS One. 2009;4:e7988.
17. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-1189. (Pubitemid 46594151)
18. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Fascicle 23. 3rd series. Atlas of tumor pathology series. Washington, D.C.: Armed Forces Institute of Pathology; 1998.
19. Shah VI, Freites ON, Maxwell P, et al. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol. 2003;3:221-224. (Pubitemid 36308039)
20. Shah SP, Kobel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;26: 2719-2729.
21. Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histologic mimics. Histopathology. 1997;31:67-74. (Pubitemid 27314508)
22. Stewart CJ, Nandini CL, Richmond JA. Value ofA103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J Clin Pathol. 2000;53:206-211. (Pubitemid 30163604)
23. Tavassoli FA, Devilee P. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Tract. Lyon: IARC Press WHO; 2003.
24. Zhao C, Vinh TN, McManus K, et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol. 2009;33:354-366.